Novel PARP inhibitors with potent antitumor activity as single-agent and combination therapies

被引：7
|
作者：
Wang, Bing
Chu, Daniel
Feng, Ying
Yu, Xin
Myers, Peter
Post, Leonard
Shen, Yucliao
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-A121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A121
引用
收藏
页数：3
相关论文
共 50 条
  • [31] In vitro antitumor activity of 9-nitro camptothecin as a single agent and in combination with other antitumor drugs
    Bernacki, RJ
    Pera, P
    Gambacorta, P
    Brun, Y
    Greco, WR
    CAMPTOTHECINS: UNFOLDING THEIR ANTICANER POTENTIAL, 2000, 922 : 293 - 297
  • [32] ATRC-101 DRIVES POTENT SINGLE-AGENT ACTIVITY IN MOUSE SYNGENEIC TUMOR MODELS VIA A NOVEL CELLULAR MECHANISM OF ACTION
    Leung, Yvonne
    Vad, Nikhil
    Ye, Anne
    Santos, Daniel
    Cao, Wei
    Czupalla, Cathrin
    Vivian, John
    Williams, Carlene
    Sapugay, Judevin
    Harbell, Michael
    Lippow, Shaun
    Carroll, Chantia
    Kates, Lance
    Haugen, Benjamin
    Bolton, Gary
    Armanini, Mark
    Aydin, Iraz
    Whidden, Mark
    Velasco-Delgado, Mauricio
    Chu, Felix
    Wechsler, Erin
    Ngan Nguyen
    Robinson, William
    Serafini, Tito
    Emerling, Daniel
    Greenberg, Norman
    Manning-Bog, Amy
    Scholz, Alexander
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A413 - A414
  • [33] Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: Single-agent and combination studies
    Foss, FM
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 58 - 63
  • [34] NMS-812, a novel potent PERK inhibitor that also inhibits GCN2, exhibits strong antitumor activity as single agent and in combination in preclinical models
    Perrera, Claudia
    Pulici, Maurizio
    Banfi, Patrizia
    Avanzi, Nilla
    Carenzi, Davide
    Casero, Daniele
    Ciavolella, Antonella
    Gianellini, Laura
    Gasparri, Fabio
    Saturno, Grazia
    Valsasina, Barbara
    Ardini, Elena
    Montagnoli, Alessia
    Galvani, Arturo P.
    Isacchi, Antonella
    CANCER RESEARCH, 2023, 83 (07)
  • [35] A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo
    Jones, Philip
    Altamura, Sergio
    De Francesco, Raffaele
    Paz, Odalys Gonzalez
    Kinzel, Olaf
    Mesiti, Giuseppe
    Monteagudo, Edith
    Pescatore, Giovanna
    Rowley, Michael
    Verdirame, Maria
    Steinkijhler, Christian
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) : 2350 - 2353
  • [36] SINGLE-AGENT AND COMBINATION CHEMOTHERAPY WITH ETOPOSIDE IN THE ACUTE LEUKEMIAS OF CHILDHOOD
    RIVERA, G
    BOWMAN, WP
    LOOK, AT
    EVANS, WE
    KALWINSKY, D
    DAHL, GV
    CANCER TREATMENT REVIEWS, 1982, 9 : 53 - 57
  • [37] Combination versus single-agent as palliative chemotherapy for gastric cancer
    Choi, Jin-Hyuk
    Choi, Yong Won
    Kang, Seok Yun
    Jeong, Geum Sook
    Lee, Hyun Woo
    Jeong, Seong Hyun
    Park, Joon Seong
    Ahn, Mi Sun
    Sheen, Seung Soo
    BMC CANCER, 2020, 20 (01)
  • [38] Combination versus single-agent as palliative chemotherapy for gastric cancer
    Jin-Hyuk Choi
    Yong Won Choi
    Seok Yun Kang
    Geum Sook Jeong
    Hyun Woo Lee
    Seong Hyun Jeong
    Joon Seong Park
    Mi Sun Ahn
    Seung Soo Sheen
    BMC Cancer, 20
  • [39] Pemetrexed: Single-agent and combination phase I study overview
    Boyer, MJ
    Rivory, LP
    Clarke, SJ
    SEMINARS IN ONCOLOGY, 2002, 29 (06) : 18 - 23
  • [40] TRIALS OF SINGLE-AGENT AND COMBINATION CHEMOTHERAPY FOR ADVANCED CANCER OF THE PANCREAS
    HORTON, J
    GELBER, RD
    ENGSTROM, P
    FALKSON, G
    MOERTEL, C
    BRODOVSKY, H
    DOUGLASS, H
    CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 65 - 68
12345